Medicine information CLORURA DE METILTIONINIU PROVEBLUE 5mg / ml solution for injection

Product code:
W63114001
Quantity:
5
Indicated for:
methemoglobinemia
Route of administration:
injectable
Substance:
methylthioninium chloride (antidote)
ATC
V03AB17 — Various | All other therapeutic products | All other therapeutic products | Antidotes
Methylthioninium chloride, also known as methylene blue, is a medication used for the treatment of methemoglobinemia, a condition in which hemoglobin cannot efficiently carry oxygen. It works by reducing methemoglobin to functional hemoglobin.

The medication is administered intravenously, usually under medical supervision, and is effective in restoring normal oxygen transport in the blood.

Side effects may include nausea, vomiting, abdominal pain, dizziness, and, in rare cases, severe allergic reactions. Temporary blue discoloration of urine and skin is a common and harmless effect.

Consult your doctor to discuss the benefits and risks of treatment with Methylthioninium chloride. This medication must be administered exclusively in controlled environments, such as hospitals.

General data about CLORURA DE METILTIONINIU PROVEBLUE 5mg / ml

Substance:
methylthioninium chloride
Date of latest medicines list:
01-02-2026
Product code:
W63114001
Strength:
5mg / ml
Pharmaceutical form:
solution for injection
Quantity:
5
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
PIERREL S.P.A. - ITALIA
Holder:
PROVEPHARM SAS - FRANTA
Number:
682/2011/01
Shelf life:
3 years

Strengths available for methylthioninium chloride

  • 100mg/10ml
  • 5mg/ml

Official documents

The SmPC text is not displayed because a match to this medicine, strength and pharmaceutical form has not been confirmed.

Added to database:
06/06/2011
Source record updated:
19/12/2025